Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
It is an extremely positive report and it is only for disclosure to subscribers. It is easy to subscribe and I suggest that all potential investors consider doing so.
It is easy to understand the recent pick up in share price, having read the detailed report.
To quote Jim Mellon on Master Investor:
‘… Oh, and the agricultural revolution continues apace, and with Ukraine and Russian food production in potential turmoil, and phosphate and other agricultural input prices rocketing, the auguries for cell agriculture and precision fermentation just get better and better...’
Many thanks for the link and I noted, in particular, the statement:
‘… It is very probable that Agronomics will be a multi-billion dollar business in the not too distant future, in my opinion. I believe that from its lowly 22p per share today, it’s very possible that £10 per share can be reached in several years from now.‘
https://www.fool.co.uk/2021/11/06/2-high-growth-penny-stocks-to-buy-right-now/
Wow!
i'll be more than happy if the predicted rise in value is achieved, even part-way - https://walletinvestor.com/lse-stock-forecast/anic-stock-prediction - go down the page for the year-by-year forecasts
https://www.bbc.com/news/world-europe-58949867
Opportunity or competition for Immo?
What does one make of statements on another board that states that Amala Foods Plc and Amala Foods Inc are separate companies (the PLC is only a shareholder in Amala Foods Inc and not a subsidiary of the PLC)? As a result, revenues will not flow from the Inc to the PLC or be included in the PLC's accounts?
& select Orph!
You just have to register at investormeetcompany.com
In yesterday's Hybridan Small Cap Feast:
What’s cooking in the IPO kitchen?
UK SPAC (formerly Mountfield Group and now an AIM Rule 15 Shell) has applied for admission to the AQSE Growth Market. The Company recently raised £3.1m in a placing, giving the Company flexibility in pursuing a reverse take-over transaction. The Directors of the Company are currently in the process of identifying and assessing reverse takeover opportunities with a particular focus on the European medicinal cannabis sector. The Directors are working closely with specialists in this industry in order to evaluate opportunities. Due 3 June
UK SPAC (an AIM Rule 15 Cash Shell) has applied for admission to the AQSE Growth Market. The Company recently raised £3.1m in a placing, giving the Company flexibility in pursuing a reverse take-over transaction. The Directors of the Company are currently in the process of identifying and assessing reverse takeover opportunities with a particular focus on the European medicinal cannabis sector. The Directors are working closely with specialists in this industry in order to evaluate opportunities. Due 3 June
Yes rugs on two occasions but received what seems their stock response:
'Thank you for your interest in the recently announced Agronomics Fundraising.
On 11 May, the company announced their intention to raise a minimum of £50 million via a Placing and a Broker Option.
As the company decided to raise funds via a Placing, we are unable to act in a retail capacity. If you are a Qualifying Professional Investor, we were able to submit an order on your behalf, however books have now closed.
Unfortunately, we are unable to participate in the Broker Option as we do not have an existing business relationship with the bookrunner involved in the fundraising.'
The offer would have been significantly more oversubscribed had those investors stuck with HL etc been able to apply for the 22p shares.
Sadly, there has been no comment from the Board, in respect of those disadvantaged shareholders (part owners of the company).